Author

Kevin Chiu

Institution: Mount Vernon Cancer Centre

Observed institution: Mount Vernon Cancer Centre

ORCID: 0000-0002-4924-6285

Observed ORCID: 0000-0002-4924-6285

OpenAlex ID: A5133247145

Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial

2026 · David J Thomson, James M Price, et al. · The Lancet · 35

A sinGle-arm phase II study to assess efficacy, tOxicity, and quAlity of life following 27Gy in 6 fractions palliative intensity modulated radiotherapy with early integration of palliative care (GOAL27-6)

2026 · Kevin Chiu, Amit Gupta, et al. · Radiotherapy and Oncology · 1

Palliative Radiotherapy with 27 Gy in 6 Fractions for Head and Neck Cancer: A Single-Centre Experience of Toxicities and Clinical Outcomes

2026 · Amani A Chowdhury, Amit Gupta, et al. · Radiotherapy and Oncology · 1

696 Health-related quality of life in the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010)

2026 · Matthew Tyler, David J Thomson, et al. · Radiotherapy and Oncology

Deformable dosimetric analysis of clinical decision on adaptive Head and Neck radiotherapy - a HUman VErsus Machine comparison - HUVEM

2026 · Kevin Chiu, Hannah Price, et al. · Radiotherapy and Oncology

Efficacy, tOxicity, and quAlity of Life following 27Gy in 6 fractions palliative radiotherapy in advanced head and neck cancer - GOAL27-6

2026 · Kevin Chiu, Amit Gupta, et al. · Radiotherapy and Oncology

Works count: 6

Citation count: 37

H-index: 1

I10-index: 1